Literature DB >> 15896298

In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind beta-amyloid.

Richard R Erickson1, Lisa M Dunning, Douglas A Olson, Sheftel J Cohen, Alan T Davis, W Gibson Wood, Robert A Kratzke, Jordan L Holtzman.   

Abstract

The beta-amyloids (abetas) are the major components of the plaque observed in the brains of patients with Alzheimer's disease. The conundrum is that although they are produced in everyone during the posttranslational processing in the endoplasmic reticulum (ER) of the amyloid precursor protein (APP), deposits are only observed in the elderly. Our work suggests that normals have a carrier protein(s) keeping them in solution. Based on immunoblotting studies of cerebrospinal fluid (CSF) from normals, we find that the bulk of the abetas are bound to the ER chaperones, ERp57 and calreticulin, suggesting that these may be carrier proteins which prevent aggregation of the abetas and that the deposits are due to faulty ER posttranslational processing of APP with the failure to form this complex. If membrane protein synthesis is similarly affected, it could explain the neuronal dysfunction characteristic of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896298     DOI: 10.1016/j.bbrc.2005.04.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Endoplasmic reticulum enrollment in Alzheimer's disease.

Authors:  Ricardo J S Viana; Ana F Nunes; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-20       Impact factor: 5.590

2.  Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis.

Authors:  Danilo Bilches Medinas; Sajid Malik; Esra Yıldız-Bölükbaşı; Janina Borgonovo; Mirva J Saaranen; Hery Urra; Eduardo Pulgar; Muhammad Afzal; Darwin Contreras; Madison T Wright; Felipe Bodaleo; Gabriel Quiroz; Pablo Rozas; Sara Mumtaz; Rodrigo Díaz; Carlos Rozas; Felipe Cabral-Miranda; Ricardo Piña; Vicente Valenzuela; Ozgun Uyan; Christopher Reardon; Ute Woehlbier; Robert H Brown; Miguel Sena-Esteves; Christian Gonzalez-Billault; Bernardo Morales; Lars Plate; Lloyd W Ruddock; Miguel L Concha; Claudio Hetz; Aslıhan Tolun
Journal:  EMBO J       Date:  2021-12-14       Impact factor: 11.598

Review 3.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 4.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

Review 5.  The unfolded protein response in Alzheimer's disease.

Authors:  Víctor Hugo Cornejo; Claudio Hetz
Journal:  Semin Immunopathol       Date:  2013-04-23       Impact factor: 9.623

6.  Protective role for the disulfide isomerase PDIA3 in methamphetamine neurotoxicity.

Authors:  Gurudutt Pendyala; Carly Ninemire; Howard S Fox
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

7.  SERPINA2 is a novel gene with a divergent function from SERPINA1.

Authors:  Patrícia Isabel Marques; Zélia Ferreira; Manuella Martins; Joana Figueiredo; Diana Isabel Silva; Patrícia Castro; Ramiro Morales-Hojas; Joana Simões-Correia; Susana Seixas
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  Diosgenin is an exogenous activator of 1,25D₃-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice.

Authors:  Chihiro Tohda; Takuya Urano; Masahito Umezaki; Ilka Nemere; Tomoharu Kuboyama
Journal:  Sci Rep       Date:  2012-07-26       Impact factor: 4.379

9.  Cellular and animal models for high-throughput screening of therapeutic agents for the treatment of the diseases of the elderly in general and Alzheimer's disease in particular(†).

Authors:  Jordan L Holtzman
Journal:  Front Pharmacol       Date:  2013-05-13       Impact factor: 5.810

10.  Generation of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.

Authors:  Nina Stemmer; Elena Strekalova; Nevena Djogo; Frank Plöger; Gabriele Loers; David Lutz; Friedrich Buck; Marek Michalak; Melitta Schachner; Ralf Kleene
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.